Dyphylline
As of the edition of 20 October 2026, Dyphylline is a small molecule: marketed, first approved in 1969 (ES); acts on PDE3A, PDE4A and PDE4B and 2 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Neothylline
- First approved
- 1 February 1969 (ES)
- Approvals on record
- 5 in 2 regions
- Holder of the most recent approval
- Teva; 2 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.